Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45 USD | +6.38% |
|
+40.80% | +76.75% |
15/07 | Transcript : Kymera Therapeutics, Inc. Presents at UBS Virtual Targeted Protein Degradation Day, Jul-15-2024 01:00 PM | |
09/07 | Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.75% | 2.6B | |
+22.15% | 46.55B | |
+45.94% | 41.84B | |
-2.37% | 40.84B | |
+33.84% | 32.95B | |
-6.35% | 28.27B | |
+20.42% | 27.78B | |
+48.83% | 14.26B | |
+45.00% | 13.69B | |
+0.06% | 12.18B |
- Stock Market
- Equities
- KYMR Stock
- News Kymera Therapeutics, Inc.
- B. Riley Adjusts Price Target on Kymera Therapeutics to $36 From $31, Maintains Neutral Rating